Xuejing Lin

766 total citations
28 papers, 565 citations indexed

About

Xuejing Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xuejing Lin has authored 28 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Xuejing Lin's work include MicroRNA in disease regulation (4 papers), Cancer-related Molecular Pathways (4 papers) and Ubiquitin and proteasome pathways (3 papers). Xuejing Lin is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related Molecular Pathways (4 papers) and Ubiquitin and proteasome pathways (3 papers). Xuejing Lin collaborates with scholars based in China, United States and United Kingdom. Xuejing Lin's co-authors include Changqing Su, Zhangxiao Peng, R. Todd Ogden, Chunying Liu, Weidan Ji, Heidi M. Schambra, Dylan J. Edwards, John W. Krakauer, Asif Rahman and Bin Sun and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Gene.

In The Last Decade

Xuejing Lin

24 papers receiving 562 citations

Peers

Xuejing Lin
Liling Wang China
Shuohui Gao China
Mahdi Goudarzvand Iran
B. Mahalakshmi Taiwan
Xiaohui Qiu China
Ricardo Quiroz‐Baez Mexico
Ravi Rajmohan United States
Yuchi Zhang China
Ren‐Shyan Liu Taiwan
Liling Wang China
Xuejing Lin
Citations per year, relative to Xuejing Lin Xuejing Lin (= 1×) peers Liling Wang

Countries citing papers authored by Xuejing Lin

Since Specialization
Citations

This map shows the geographic impact of Xuejing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejing Lin more than expected).

Fields of papers citing papers by Xuejing Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuejing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejing Lin. The network helps show where Xuejing Lin may publish in the future.

Co-authorship network of co-authors of Xuejing Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xuejing Lin. A scholar is included among the top collaborators of Xuejing Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuejing Lin. Xuejing Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Liang, Haitong Zhang, Lingyu Wang, et al.. (2025). Superhydrophilic hydrogel-enhanced conductive MOF-based wearable sweat sensors with anti-lipid biofouling capability. Microchemical Journal. 215. 114302–114302.
2.
Tian, Wei‐Cheng, Yue Zhuo, Min Pan, et al.. (2025). Revealing the Impact of Mono(2‐ethylhexyl) Phthalate (MEHP) on Prostate Cancer Based on Network Toxicology and Molecular Docking Approaches. Journal of Applied Toxicology. 45(10). 2078–2094.
3.
Zhang, Hao‐Li, Lingyu Wang, Xuejing Lin, et al.. (2025). Thermoresponsive dynamic wet-adhesive epidermal interface for motion-robust multiplexed sweat biosensing. Biosensors and Bioelectronics. 290. 117949–117949. 2 indexed citations
4.
Liu, Yanli, Yifan Fu, Haitong Zhang, et al.. (2025). Synergistic Tuning of Active Sites and π-Conjugation in 2D Conductive MOFs Boosts Uric Acid Electrosensing. Chemosensors. 13(9). 318–318.
5.
Tang, Erjiang, Xuejing Lin, Ying Chen, et al.. (2024). Clinical performance of the TrueMark™ MSI assay for microsatellite instability detection in a Chinese colorectal cancer cohort. Gene. 927. 148745–148745. 1 indexed citations
6.
Lin, Xuejing, et al.. (2023). Toxoplasma gondii autophagy-related protein ATG7 maintains apicoplast inheritance by stabilizing and lipidating ATG8. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(1). 166891–166891. 5 indexed citations
7.
Liu, Chunying, Xuejing Lin, Bin Sun, et al.. (2021). PRCC reduces the sensitivity of cancer cells to DNA damage by inhibiting JNK and ATM/ATR pathways and results in a poor prognosis in hepatocellular carcinoma. Cell & Bioscience. 11(1). 185–185. 2 indexed citations
8.
Milak, Matthew S., Zhengchao Dong, Lawrence S. Kegeles, et al.. (2020). Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression. JAMA Network Open. 3(8). e2013211–e2013211. 43 indexed citations
9.
Yuan, Minlan, Harry Rubin‐Falcone, Xuejing Lin, et al.. (2020). Smaller left hippocampal subfield CA1 volume is associated with reported childhood physical and/or sexual abuse in major depression: A pilot study. Journal of Affective Disorders. 272. 348–354. 14 indexed citations
10.
Ananth, Mala, Elizabeth Bartlett, Christine DeLorenzo, et al.. (2020). Prediction of lithium treatment response in bipolar depression using 5-HTT and 5-HT1A PET. European Journal of Nuclear Medicine and Molecular Imaging. 47(10). 2417–2428. 9 indexed citations
11.
Rubin‐Falcone, Harry, R. Todd Ogden, Xuejing Lin, et al.. (2019). Antidepressant medication exposure and 5‐HT1A autoreceptor binding in major depressive disorder. Synapse. 73(6). e22089–e22089. 16 indexed citations
12.
13.
Rizk, Mina, Harry Rubin‐Falcone, Xuejing Lin, et al.. (2018). Gray matter volumetric study of major depression and suicidal behavior. Psychiatry Research Neuroimaging. 283. 16–23. 23 indexed citations
14.
Yin, Haisen, Risheng Que, Chunying Liu, et al.. (2018). Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma. Cancer Letters. 425. 54–64. 42 indexed citations
15.
Peng, Zhangxiao, Yan Wang, Jianhui Fan, et al.. (2017). Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway. Scientific Reports. 7(1). 41254–41254. 69 indexed citations
16.
Mao, Ziming, Chunying Liu, Xuejing Lin, Bin Sun, & Changqing Su. (2017). PPP2R5A: A multirole protein phosphatase subunit in regulating cancer development. Cancer Letters. 414. 222–229. 18 indexed citations
17.
18.
19.
20.
Schambra, Heidi M., R. Todd Ogden, Xuejing Lin, et al.. (2015). The reliability of repeated TMS measures in older adults and in patients with subacute and chronic stroke. Frontiers in Cellular Neuroscience. 9. 335–335. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liling Wang Breakdown of academic impact, for papers by Shuohui Gao Breakdown of academic impact, for papers by Mahdi Goudarzvand Breakdown of academic impact, for papers by B. Mahalakshmi Breakdown of academic impact, for papers by Xiaohui Qiu Breakdown of academic impact, for papers by Ricardo Quiroz‐Baez Breakdown of academic impact, for papers by Ravi Rajmohan Breakdown of academic impact, for papers by Yuchi Zhang Breakdown of academic impact, for papers by Ren‐Shyan Liu
Rankless by CCL
2026